Dear Colleagues from the biophysics and drug discovery community,
For the third time around, the COVID-19 pandemic forces us to hold a virtual event. We hope we will soon be able to go back to live events - sanitary conditions permitting - for the 8th NovAliX Conference which will take place in Munich in May 2022.
In between, the aim of this 3rd NovAliX virtual Conference is to offer our colleagues from Asia the opportunity to listen to high-quality speakers at a convenient schedule. Participants from other timezones are of course also invited to join us on November 4, 2021 from 5:00PM to 7:00PM Japan Standard Time (JST) / from 9:00AM to 11:00AM Central European Time (CET) for this new virtual session.
The topics covered include the use of biophysics to tackle challenging targets, illustrated by Dirk Kessler from Boehringer Ingelheim in the case of KRAS and related targets, and the use of cryo-EM in GPCR drug discovery by Stacey Southall from Sosei Heptares.
Registration is free of charge and open to any scientist interested in the use of biophysics in drug discovery.
So please save the date, I hope you will join us on November 4th !
Chairman & Scientific Organiser of the NovAliX Conferences